^CtmPrP and ER stress

References

• Prusiner SB. Prions. Proc Natl Acad Sci USA 1998; 95:13363 - 13383
   PubMed Web of Science ®Google Scholar
• Harris DA. Cellular biology of prion diseases. Clin Microbiol Rev 1999; 12:429 - 444
   PubMed Web of Science ®Google Scholar
• Telling GC. Transgenic mouse models of prion diseases. Methods Mol Biol 2008; 459:249 - 263
   Google Scholar
• Hegde RS, Tremblay P, Groth D, DeArmond SJ, Prusiner SB, Lingappa VR. Transmissible and genetic prion diseases share a common pathway of neurodegeneration. Nature 1999; 402:822 - 826
   PubMed Web of Science ®Google Scholar
• Kovács GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H. Mutations of the prion protein gene phenotypic spectrum. J Neurol 2002; 249:1567 - 1582
   PubMed Web of Science ®Google Scholar
• Rodriguez MM, Peoc'h K, Haïk S, Bouchet C, Vernengo L, Mañana G, et al. A novel mutation (G114V) in the prion protein gene in a family with inherited prion disease. Neurology 2005; 64:1455 - 1457
   Google Scholar
• Baldwin MA. Analysis of glycosylphosphatidylinositol protein anchors: the prion protein. Methods Enzymol 2005; 405:172 - 187
   Web of Science ®Google Scholar
• Hegde RS, Mastrianni JA, Scott MR, DeFea KA, Tremblay P, Torchia M, et al. A transmembrane form of the prion protein in neurodegenerative disease. Science 1998; 279:827 - 834
   PubMed Web of Science ®Google Scholar
• Lopez CD, Yost CS, Prusiner SB, Myers RM, Lingappa VR. Unusual topogenic sequence directs prion protein biogenesis. Science 1990; 248:226 - 229
   Google Scholar
• Yost CS, Lopez CD, Prusiner SB, Myers RM, Lingappa VR. Non-hydrophobic extracytoplasmic determinant of stop transfer in the prion protein. Nature 1990; 343:669 - 672
   PubMed Web of Science ®Google Scholar
• Stewart RS, Harris DA. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J Biol Chem 2003; 278:45960 - 45968
   PubMed Web of Science ®Google Scholar
• Tateishi J, Kitamoto T, Hoque MZ, Furukawa H. Experimental transmission of Creutzfeldt-Jakob disease and related diseases to rodents. Neurology 1996; 46:532 - 537
   PubMed Web of Science ®Google Scholar
• Stewart RS, Piccardo P, Ghetti B, Harris DA. Neurodegenerative illness in transgenic mice expressing a transmembrane form of the prion protein. J Neurosci 2005; 25:3469 - 3477
   PubMed Web of Science ®Google Scholar
• Harris DA. Trafficking, turnover and membrane topology of PrP. Br Med Bull 2003; 66:71 - 85
   PubMed Web of Science ®Google Scholar
• Paschen W. Endoplasmic reticulum dysfunction in brain pathology: critical role of protein synthesis. Curr Neurovasc Res 2004; 1:173 - 181
   Google Scholar
• Kaufman RJ. Stress signaling from the lumen of the endoplasmic reticulum: coordination of gene transcriptional and translational controls. Genes Dev 1999; 13:1211 - 1233
   PubMed Web of Science ®Google Scholar
• Averous J, Bruhat A, Jousse C, Carraro V, Thiel G, Fafournoux P. Induction of CHOP expression by amino acid limitation requires both ATF4 expression and ATF2 phosphorylation. J Biol Chem 2004; 279:5288 - 5297
   PubMed Web of Science ®Google Scholar
• Wang X, Shi Q, Xu K, Gao C, Chen C, Li XL, et al. Familial CJD associated PrP mutants within transmembrane region induced Ctm-PrP retention in ER and triggered apoptosis by ER stress in SH-SY5Y cells. PLoS One 2011; 6:14602
   Web of Science ®Google Scholar
• Lutz J, Brabeck C, Niemann HH, Kloz U, Korth C, Lingappa VR, et al. Microdeletions within the hydrophobic core region of cellular prion protein alter its topology and metabolism. Biochem Biophys Res Commun 2010; 393:439 - 444
   PubMed Web of Science ®Google Scholar
• Piccardo P, Liepnieks JJ, William A, Dlouhy SR, Farlow MR, Young K, et al. Prion proteins with different conformations accumulate in Gerstmann-Sträussler-Scheinker disease caused by A117V and F198S mutations. Am J Pathol 2001; 158:2201 - 2207
   PubMed Web of Science ®Google Scholar
• Ye J, Han J, Shi Q, Zhang BY, Wang GR, Tian C, et al. Human prion disease with a G114V mutation and epidemiological studies in a Chinese family: a case series. J Med Case Reports 2008; 2:331
   Google Scholar
• Stewart RS, Harris DA. Mutational analysis of topological determinants in prion protein (PrP) and measurement of transmembrane and cytosolic PrP during prion infection. J Biol Chem 2003; 278:45960 - 45968
   PubMed Web of Science ®Google Scholar
• Biasini E, Medrano AZ, Thellung S, Chiesa R, Harris DA. Multiple biochemical similarities between infectious and non-infectious aggregates of a prion protein carrying an octapeptide insertion. J Neurochem 2008; 104:1293 - 1308
   PubMed Web of Science ®Google Scholar
• Xu K, Wang X, Shi Q, Chen C, Tian C, Li XL, et al. Human prion protein mutants with deleted and inserted octarepeats undergo different pathways to trigger cell apoptosis. J Mol Neurosci 2011; 43:225 - 234
   Google Scholar
• Flechsig E, Shmerling D, Hegyi I, Raeber AJ, Fischer M, Cozzio A, et al. Prion protein devoid of the octapeptide repeat region restores susceptibility to scrapie in PrP knockout mice. Neuron 2000; 27:399 - 408
   PubMed Web of Science ®Google Scholar
• Tateishi J, Kitamoto T, Kretzschmar H, Mehraein P. Immunhistological evaluation of Creutzfeldt-Jakob disease with reference to the type PrPres deposition. Clin Neuropathol 1996; 15:358 - 360
   PubMed Web of Science ®Google Scholar
• Liu YH, Han YL, Song J, Wang Y, Jing YY, Shi Q, Tian C, et al. Heat shock protein 104 inhibited the fibrillization of prion peptide 106–126 and disassembled prion peptide 106–126 fibrils in vitro. Int J Biochem Cell Biol 2011; 43:768 - 774
   PubMed Web of Science ®Google Scholar